Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2019 4
2020 3901
2021 5643
2022 4966
2023 3656
2024 969

Text availability

Article attribute

Article type

Publication date

Search Results

16,998 results

Results by year

Filters applied: . Clear all
Page 1
Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19.
Majumder J, Minko T. Majumder J, et al. AAPS J. 2021 Jan 5;23(1):14. doi: 10.1208/s12248-020-00532-2. AAPS J. 2021. PMID: 33400058 Free PMC article. Review.
The ongoing pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has made a serious public health threat worldwide with millio …
The ongoing pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory …
COVID-19 vaccination in cancer patients: a narrative review.
Seneviratne SL, Yasawardene P, Wijerathne W, Somawardana B. Seneviratne SL, et al. J Int Med Res. 2022 Mar;50(3):3000605221086155. doi: 10.1177/03000605221086155. J Int Med Res. 2022. PMID: 35313761 Free PMC article. Review.
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has affected over 220 million individuals worldwide, and has been shown to cause increa …
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronav …
COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety.
Fendler A, de Vries EGE, GeurtsvanKessel CH, Haanen JB, Wörmann B, Turajlic S, von Lilienfeld-Toal M. Fendler A, et al. Nat Rev Clin Oncol. 2022 Jun;19(6):385-401. doi: 10.1038/s41571-022-00610-8. Epub 2022 Mar 11. Nat Rev Clin Oncol. 2022. PMID: 35277694 Free PMC article. Review.
Patients with cancer have a higher risk of severe coronavirus disease (COVID-19) and associated mortality than the general population. ...In this Review, we summarize the current knowledge generated in studies conducted since COVID-19 …
Patients with cancer have a higher risk of severe coronavirus disease (COVID-19) and associated mortality …
COVID-19 vaccine development: milestones, lessons and prospects.
Li M, Wang H, Tian L, Pang Z, Yang Q, Huang T, Fan J, Song L, Tong Y, Fan H. Li M, et al. Signal Transduct Target Ther. 2022 May 3;7(1):146. doi: 10.1038/s41392-022-00996-y. Signal Transduct Target Ther. 2022. PMID: 35504917 Free PMC article. Review.
With the constantly mutating of SARS-CoV-2 and the emergence of Variants of Concern (VOC), the implementation of vaccination is critically important. ...However, some viral vector or mRNA vaccines may be associated with complications like thrombocytopenia and …
With the constantly mutating of SARS-CoV-2 and the emergence of Variants of Concern (VOC), the implementation of vaccin …
Vaccination of cancer patients against COVID-19: towards the end of a dilemma.
Mandal A, Singh P, Samaddar A, Singh D, Verma M, Rakesh A, Ranjan R. Mandal A, et al. Med Oncol. 2021 Jul 8;38(8):92. doi: 10.1007/s12032-021-01540-8. Med Oncol. 2021. PMID: 34235592 Free PMC article. Review.
Vaccines have been proved to reduce the risk of developing severe illness and are emerging as vital tools in the battle against COVID-19. As per the GLOBOCAN database, nearly 19.3 million new cancer cases have been reported in 2020 globally, which posed a sig …
Vaccines have been proved to reduce the risk of developing severe illness and are emerging as vital tools in the battle against COVID …
COVID-19: Virology, biology and novel laboratory diagnosis.
Mohamadian M, Chiti H, Shoghli A, Biglari S, Parsamanesh N, Esmaeilzadeh A. Mohamadian M, et al. J Gene Med. 2021 Feb;23(2):e3303. doi: 10.1002/jgm.3303. Epub 2021 Jan 6. J Gene Med. 2021. PMID: 33305456 Free PMC article. Review.
BACKGROUND: At the end of December 2019, a novel coronavirus tentatively named SARS-CoV-2 in Wuhan, a central city in China, was announced by the World Health Organization. ...DISCUSSION: SARS-CoV-2 infected patients usually …
BACKGROUND: At the end of December 2019, a novel coronavirus tentatively named SARS-CoV-2 in Wuhan, a central ci …
Challenges posed by COVID-19 in cancer patients: A narrative review.
Mohseni Afshar Z, Hosseinzadeh R, Barary M, Ebrahimpour S, Alijanpour A, Sayad B, Hosseinzadeh D, Miri SR, Sio TT, Sullman MJM, Carson-Chahhoud K, Babazadeh A. Mohseni Afshar Z, et al. Cancer Med. 2022 Feb;11(4):1119-1135. doi: 10.1002/cam4.4519. Epub 2021 Dec 23. Cancer Med. 2022. PMID: 34951152 Free PMC article. Review.
A novel coronavirus, or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was identified as the causative agent of coronavirus disease 2019 (COVID-19). ...Thus, the main objecti …
A novel coronavirus, or severe acute respiratory syndrome coronavirus 2 (SARS-CoV …
COVID-19 in patients with hematologic malignancy.
Langerbeins P, Hallek M. Langerbeins P, et al. Blood. 2022 Jul 21;140(3):236-252. doi: 10.1182/blood.2021012251. Blood. 2022. PMID: 35544585 Free PMC article.
Several risk factors including advanced age, previous illnesses, and a compromised immune system contribute to an unfavorable outcome. In patients with hematologic malignancy, the immune response to severe acute respiratory syndrome coronavir …
Several risk factors including advanced age, previous illnesses, and a compromised immune system contribute to an unfavorable outcome. In …
COVID-19 vaccine development from the perspective of cancer patients.
He Y, Ding Y, Cao B, Huang Y, Wang X. He Y, et al. Hum Vaccin Immunother. 2021 Oct 3;17(10):3281-3287. doi: 10.1080/21645515.2021.1943988. Epub 2021 Jun 25. Hum Vaccin Immunother. 2021. PMID: 34170788 Free PMC article. Review.
This mini-review aims to discuss the impact of COVID-19 on cancer patients, and the urgent need of COVID-19 vaccines for cancer patients. ...In addition, we included an original survey of the acceptance of the COVI …
This mini-review aims to discuss the impact of COVID-19 on cancer patients, and the urgent need of COVID- …
[COVID-19 Vaccination for Cancer Patients: Progress and Preliminary Recommendations].
Wang L, Xu Y, Zhang L, Fan J, Pan R, Wang J, Wang M. Wang L, et al. Zhongguo Fei Ai Za Zhi. 2021 Jun 20;24(6):377-383. doi: 10.3779/j.issn.1009-3419.2021.101.18. Epub 2021 May 24. Zhongguo Fei Ai Za Zhi. 2021. PMID: 34024060 Free PMC article. Review. Chinese.
High infection risk and higher serious incident and mortality rates have been shown in cancer patients with COVID-19. Therefore, cancer patients should be the priority group for COVID-19 prevention. Until now, data of COV …
High infection risk and higher serious incident and mortality rates have been shown in cancer patients with COVID-19 …
16,998 results
You have reached the last available page of results. Please see the User Guide for more information.

Searches related to "cancer patients covid-19"